Natural Capsules Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....

A C C R E D I T E D ISO/IEC 17021 CERTIFICATION BODY Date: September 01, 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, PJ Towers Exchange Plaza, C-1, Block G Dalal Street, Bandra Kurla Complex, Bandra (E) Mumbai – 400001 Mumbai – 400051 Scrip Code: 524654 Symbol: NATCAPSUQ Sub: Intimation under Regulation 29 and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Board Meeting scheduled at Shorter Notice on September 02, 2026 Dear Sir / Madam, Pursuant to Regulation 29 and Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we wish to inform you that a meeting of the Board of Directors of Natural Capsules Limited is scheduled to be held today, Wednesday, September 02, 2026, at Shorter Notice. Purpose of the Board Meeting: 1. Consideration of Valuation Report: To consider, evaluate, and take on record the updated Valuation Report issued by the Registered Valuer, as requested/queried by the Stock Exchanges (BSE & NSE) in relation to the proposed Preferential Issue of Equity Shares/Convertible Securities. 2. Revision of Issue/Allotment Price and Quantity: To consider, evaluate, and approve the revised issue/allotment price and Quantity of Equity shares and Warrants to be allotted for the proposed preferential issue of shares/securities, followed by the change in price arrived at pursuant to the Independent Valuation Report and applicable provisions of Chapter V of the SEBI (ICDR) Regulations, 2018. 3. Approval of Revised Notice & Schedule: To approve the Corrigendum to the Notice of General Meeting and modify consequential operational matters related to the Preferential Issue. Reason for Shorter Notice: The meeting is being convened at shorter notice due to the urgent requirement to respond to queries raised by BSE & NSE regarding the valuation report and the consequent necessity to revise the allotment price strictly within statutory timelines. Consent for holding the Board Meeting at shorter notice has been duly obtained from the Directors in accordance with Section 173(3) of the Companies Act, 2013 and Secretarial Standard-1 (SS-1). Trading Window Closure: In terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to Regulate, Monitor, and Report Trading by Designated Persons, the Trading Window for dealing in the securities of the Company remained closed for all Designated Persons and their immediate relatives till 48 hours after declaration/outcome of this Board Meeting regarding the financial results for quarter ended June 30, 2026. We request you to kindly take the above information on record and disseminate the same on your respective websites. Thanking You, Yours Faithfully, For Natural Capsules Limited Sunil L Mundra Managing Director DIN:00214304